ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

CLADRIBINUM

Active substance (INN) · ATC L01BB04 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L002G	SCLEROZA MULTIPLĂ - TRATAMENT IMUNOMODULATOR	In force	mentioned in the text	C2-P4	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
LEUJECT 2 mg/ml	SOL INJ.	2mg/ml	ATNAHS PHARMA NETHERLANDS B.V. - DANEMARCA	L01BB04	PR
LITAK 2 mg/ml	SOL. INJ.	2mg/ml	LIPOMED GMBH - GERMANIA	L01BB04	PR
MAVENCLAD 10 mg	COMPR.	10mg	MERCK EUROPE B.V. - OLANDA	L04AA40	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.